Govindan R - Search Results

1

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

Morgensztern D, Campo MJ, Dahlberg SE, Doebele RC, Garon E, Gerber DE, Goldberg SB, Hammerman PS, Heist RS, Hensing T, Horn L, Ramalingam SS, Rudin CM, Salgia R, Sequist LV, Shaw AT, Simon GR, Somaiah N, Spigel DR, Wrangle J, Johnson D, Herbst RS, Bunn P, Govindan R. Morgensztern D, et al. Among authors: govindan r. J Thorac Oncol. 2015 Jan;10(1 Suppl 1):S1-63. doi: 10.1097/JTO.0000000000000405. J Thorac Oncol. 2015. PMID: 25535693 Free PMC article.

2

Practical issues in the management of the patient with small cell lung cancer.

Govindan R, Ihde DC. Govindan R, et al. Chest Surg Clin N Am. 1997 Feb;7(1):167-81. Chest Surg Clin N Am. 1997. PMID: 9001763 Review.

3

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

4

Management of patients with non-small cell lung cancer and poor performance status.

Govindan R. Govindan R. Curr Treat Options Oncol. 2003 Feb;4(1):55-9. doi: 10.1007/s11864-003-0031-x. Curr Treat Options Oncol. 2003. PMID: 12525279 Review.

5

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.

Vollmer RT, Govindan R, Graziano SL, Gamble G, Garst J, Kelley MJ, Christenson RH. Vollmer RT, et al. Among authors: govindan r. Clin Cancer Res. 2003 May;9(5):1728-33. Clin Cancer Res. 2003. PMID: 12738727

6

Novel agents in the treatment of lung cancer: conference summary statement.

Lynch TJ, Adjei AA, Bunn PA Jr, DuBois RN, Gandara DR, Giaccone G, Govindan R, Herbst RS, Johnson BE, Khuri FR, Perez-Soler R, Rosell R, Rowinsky EK, Sandler AB, Scagliotti GV, Schiller JH, Shapiro GI, Socinski MA, Hart CS. Lynch TJ, et al. Among authors: govindan r. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4199s-4204s. doi: 10.1158/1078-0432.CCR-040021. Clin Cancer Res. 2004. PMID: 15217958 No abstract available.

7

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

8

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

9

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.

Govindan R, Garfield DH. Govindan R, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):27-31. doi: 10.1053/j.seminoncol.2004.10.006. Semin Oncol. 2004. PMID: 15599832 Review.

10

A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

Govindan R, Lim WT, Arquette MA, Goodner SA, Fears CL, Mortimer JE, Fracasso PM. Govindan R, et al. Oncol Rep. 2006 Jan;15(1):123-7. Oncol Rep. 2006. PMID: 16328044 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters